Company Profile
Sunrise Group (operating as Sunrise SA) is a Belgium-based sleep health technology company and medical device manufacturer, headquartered in Namur, Belgium, with U.S. operations through its acquired Dreem Health clinic. Founded on June 20, 2015, the company operates as an independent privately-held entity having raised a total of $58 million, serving patients and healthcare providers across 49 U.S. states and select European markets.
Core Products and Technologies
Home Sleep Apnea Testing
• Mandibular Sensor: Ultra-lightweight chin-worn device that measures mandibular jaw movements for at-home obstructive sleep apnea diagnosis
• Companion App: Patient-facing mobile interface guiding multi-night testing and transmitting data to cloud-based analysis platforms
Digital Sleep Clinic
• Dreem Health Platform: Virtual sleep clinic connecting patients to licensed sleep specialists for diagnosis and treatment
• AI Analysis Engine: Proprietary algorithm processing mandibular movement bio-signals to detect sleep-disordered breathing and generate automated reports
• Care Coordination Suite: Insurance-covered telehealth pathway integrating home testing, specialist consultation and personalized therapy selection
Market Position and Certifications
Sunrise Group holds a pioneering position in the home sleep apnea testing and virtual sleep medicine market, competing with ResMed and Nox Medical. Key strengths include:
• 10+ years of European sleep technology research and development heritage
• Mandibular Jaw Movement (MJM) Technology: Direct bio-signal measurement validated against polysomnography in an 848-patient study in France
• Regulatory compliance: FDA 510(k) cleared (2023), CE marked for European distribution
• Payor coverage: In-network with Medicare, UnitedHealthcare, Aetna, Humana, Cigna, Anthem, Blue Cross Blue Shield and Health Net of California
• Global service network: Localized technical support across major markets
Corporate Timeline
2015 — Founded in Belgium to develop AI-powered sleep diagnostic hardware
2023 — Received FDA 510(k) clearance for the mandibular home sleep apnea test
2024 — Acquired Dreem Health, a California-based telemedicine sleep clinic, to build an end-to-end care model
2025 — Raised $29 million in a funding round led by Eurazeo with participation from Amazon's Alexa Fund
2026 — Completed an 848-patient validation study in France; partnered with Humana for nationwide member access
2026 — Established inaugural U.S. Medical Advisory Board with Dr. Atul Malhotra and Dr. Diana Thiara
Target Markets and Applications
• Home Sleep Apnea Testing: Mandibular sensor for at-home obstructive sleep apnea screening and multi-night monitoring
• Virtual Sleep Medicine: Dreem Health telehealth for diagnosis and treatment of insomnia, sleep apnea and restless leg syndrome
• Integrated Care Pathways: Partnerships with insurers and referring providers for covered, end-to-end sleep disorder management
Contact Information
Global Headquarters
Address: Chaussée de Marche 598/02, 5101 Namur, Belgium
Phone: +32 81 26 11 26
Email: hello@hellosunrise.com
Website: www.hellosunrise.com
VAT Number: BE 0632 607 373
U.S. Digital Sleep Clinic
Dreem Health
Website: dreemhealth.com
